Developing knowledge about genetic systems for identification of chromosomal variations from the norm and fetus screening for effective IVF holds development prospects for this vertical over the estimate time frame. Early discovery of the chromosomal maladies, which holds potential for lowering the quantity of individuals experiencing intrinsic ailments, PGD can be performed for screening of a scope of restorative conditions, for example, Down’s syndrome, inheritable illnesses and qualities of other physiological anomaly. Expanding tolerant awareness about PGD system and rising predominance of hereditary issue among newborn children has prompted the ascent sought after for PGD alongside IVF methodology. The mix of PGD and IVF has enhanced the rate of fruitful pregnancy because of decreased odds of passing the undesired hereditary material in the developing life. Thus decreases the quantity of offspring’s conceived with acquired chromosomal variations from the norm. This can be credited to the expanded interest for Preimplantation genetic testing (PGT) administrations.
How Big is The Preimplantation Genetic Testing Market?
The Global Preimplantation Genetic Testing Market is expected to be around US$ 945 Million by 2028 at a CAGR of 10% in the given forecast period.
The major driving factors of Global Preimplantation Genetic Testing Market are as follows:
The restraining factors of Global Preimplantation Genetic Testing Market are as follows:
The Global Preimplantation Genetic Testing Market is segmented on the lines of its technology, product & service, procedure type, application, end user and regional. Based on technology segmentation it covers next generation sequencing (NGS), polymerase chain reaction (PCR), fluorescent in-situ hybridization (FISH), comparative genomic hybridization (CGH), single nucleotide polymorphism (SNP). Based on product & service segmentation it covers reagents & consumables, instruments, software & services. Based on procedure type segmentation it covers preimplantation genetic screening, preimplantation genetic diagnosis. Based on application segmentation it covers aneuploidy, structural chromosomal abnormalities, and single gene disorders, x-linked disorders, hla typing, gender identification. Based on end user segmentation it covers maternity centers & fertility clinics, hospitals, diagnostic labs, and service providers, research laboratories & academic institutes. The Global Preimplantation Genetic Testing Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Preimplantation Genetic Testing Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Preimplantation Genetic Testing Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Preimplantation Genetic Testing Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), CooperSurgical, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China) Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Preimplantation Genetic Testing Market has been segmented as below:
By Technology Analysis:
By Product & Service Analysis:
By Procedure Type Analysis:
By Application Analysis:
By End User Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Preimplantation Genetic Testing Market .
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Preimplantation Genetic Testing Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Research Methodology: Bottom-Up Approach
2.2.2 Research Methodology: Top-Down Approach
2.3 Research Design
2.4 Data Validation and Triangulation
2.4.1 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Preimplantation Genetic Diagnosis and Screening: Market Overview
4.2 Geographic Analysis: Preimplantation Genetic Diagnosis and Screening Market, By Technology (2016)
4.3 Preimplantation Genetic Testing Market , By Application, 2018 vs 2024
4.4 Preimplantation Genetic Testing Market , By Product & Service (2018 vs 2024)
4.5 Geographical Snapshot of the Preimplantation Genetic Diagnosis and Screening Market
5 Preimplantation Genetic Testing Market: Overview
5.1 Introduction
5.2 Market Evolution: Preimplantation Genetic Diagnosis and Screening Technologies
5.3 Market Dynamics
5.3.1 Major Market Drivers
5.3.1.1 Declining Fertility Rates Worldwide
5.3.1.2 Increasing Public-Private Investments in the Field of Preimplantation Genetic Testing
5.3.1.3 Rising Number of Fertility Clinics Worldwide
5.3.1.4 Technological Advancements in the Field of Genetic Analysis
5.3.1.5 High Risk of Chromosomal Abnormalities With Advancing Maternal Age
5.3.2 Major Market Restraints
5.3.2.1 High Procedural Cost Associated With Preimplantation Genetic Testing
5.3.2.2 Unfavorable Government Regulations
5.3.3 Major Market Opportunities
5.3.3.1 Growth Opportunities in Emerging Markets
5.3.3.1.1 Improving Healthcare Infrastructure
5.3.3.1.2 Growing Medical Tourism
5.3.3.1.3 Growth Initiatives By Key Market Players
5.3.3.2 Growing Awareness on Assisted Reproduction Techniques
5.3.4 Major Market Challenges
5.3.4.1 Socioethical Concerns Regarding Preimplantation Genetic Testing
5.3.4.2 Procedural Limitations of Preimplantation Genetic Testing With Advancing Age
6 Industry Insights
6.1 Value Chain Analysis
6.2 Porter’s Five Forces Analysis
6.3 Regulatory Scenario
7 Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type
7.1 Introduction
7.2 Preimplantation Genetic Screening
7.3 Preimplantation Genetic Diagnosis
8 Preimplantation Genetic Diagnosis and Screening Market, By Technology
8.1 Introduction
8.2 Next-Generation Sequencing
8.3 Polymerase Chain Reaction
8.4 Fluorescence in Situ Hybridization
8.5 Comparative Genomic Hybridization
8.6 Single-Nucleotide Polymorphism
9 Preimplantation Genetic Diagnosis and Screening Market, By Product and Service
9.1 Introduction
9.2 Reagents and Consumables
9.3 Instruments
9.4 Software and Services
10 Preimplantation Genetic Diagnosis and Screening Market, By Application
10.1 Introduction
10.2 Aneuploidy
10.3 Structural Chromosomal Abnormalities
10.3.1 Translocations
10.3.2 Deletions
10.3.3 Duplications
10.3.4 Inversions
10.4 Single Gene Disorders
10.5 X-Linked Disorders
10.6 HLA Typing
10.7 Gender Identification
11 Preimplantation Genetic Diagnosis and Screening Market, By End User
11.1 Introduction
11.2 Maternity Centers & Fertility Clinics
11.3 Hospitals, Diagnostic Labs, and Service Providers
11.4 Research Laboratories & Academic Institutes
12 Preimplantation Genetic Diagnosis and Screening Market, By Region
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.3 Europe
12.3.1 Germany
12.3.2 U.K.
12.3.3 France
12.3.4 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Rest of Asia-Pacific
12.5 Rest of the World
13 Preimplantation Genetic Testing Market: Competitive Landscape
13.1 Introduction
13.2 Leading Players in the Preimplantation Genetic Testing Market
13.3 Competitive Situation and Trends
13.3.1 Agreements, Collaborations, and Partnerships
13.3.2 Product Launches and Approvals
13.3.3 Acquisitions
13.3.4 Expansions
13.3.5 Other Developments
13.4 Global Preimplantation Genetic Diagnosis and Screening Competitive Leadership Mapping, 2017
13.4.1 Visionary Leaders
13.4.2 Innovators
13.4.3 Dynamic Differentiators
13.4.4 Emerging Companies
13.5 Competitive Leadership Mapping
13.5.1 Strength of Product Portfolio (For 25 Players)
13.5.2 Business Strategy Excellence (For 25 Players)
14 Company Profiles
14.1 Top Product Manufacturers
14.1.1 Illumina, Inc.
14.1.2 Thermo Fisher Scientific Inc.
14.1.3 Agilent Technologies, Inc.
14.1.4 Perkinelmer, Inc.
14.1.5 Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)
14.1.6 ABBott Laboratories
14.1.7 Natera, Inc.
14.1.8 Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)
14.1.9 Oxford Gene Technology
14.1.10 Yikon Genomics
14.1.11 Scigene
14.2 Top Service Provider Companies
14.2.1 Beijing Genomics Institute
14.2.2 Good Start Genetics, Inc.
14.2.3 Invicta Genetics
14.2.4 Combimatrix Corporation
14.2.5 Genea Limited
14.2.6 Progenesis
The Global Preimplantation Genetic Testing Market has been segmented as below:
By Technology Analysis:
By Product & Service Analysis:
By Procedure Type Analysis:
By Application Analysis:
By End User Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
